USFDA inspection at InvaGen manufacturing facility in Fall River, USA

A routine current Good Manufacturing Practices (cGMP) inspection was conducted by the United States Food and Drug Administration (USFDA) at the manufacturing facility of InvaGen Pharmaceuticals Inc. (wholly owned subsidiary of Cipla Ltd) located in Fall River, Massachusetts, USA, from 24th April, 2023 to 1st May, 2023.

Shares of Cipla Limited was last trading in BSE at Rs. 916.15 as compared to the previous close of Rs. 907.70. The total number of shares traded during the day was 21532 in over 1883 trades.

The stock hit an intraday high of Rs. 920.60 and intraday low of 905.90. The net turnover during the day was Rs. 19657818.00.

Source : Equity Bulls

Keywords

Cipla INE059A01026 InvaGenPharmaceuticals cGMPInspection USFDA ManufacturingFacility FallRiver Massachusetts